During the past decade, Jasper Summit Research, LLC conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 9 clinical trials were completed, i.e. on average, 69.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jasper Summit Research, LLC" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Sunovion Respiratory Development Inc." with 3 trials sponsored, "Novartis Pharmaceuticals" with 2 trials sponsored, "Bellerophon Pulse Technologies" with 1 trials sponsored and "Cephalon" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jasper Summit Research, LLC" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator, "Molecular Partners AG" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Jasper Summit Research, LLC" are "Chronic Obstructive Pulmonary Disease" (5 trials), "COPD" (3 trials), "Idiopathic Pulmonary Fibrosis" (3 trials), "Pulmonary Disease, Chronic Obstructive" (3 trials) and "Bronchiectasis" (1 trials). Many other conditions were trialed in "Jasper Summit Research, LLC" in a lesser frequency.

Most popular intervention types in "Jasper Summit Research, LLC" are "Drug" (17 trials), "Combination Product" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "SUN-101 50 mcg BID eFlow (CS) nebulizer" (2 trials), "placebo" (2 trials), "Arformoterol" (1 trials) and "Astegolimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jasper Summit Research, LLC" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Jasper Summit Research, LLC". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Jasper Summit Research, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Jasper Summit Research, LLC, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".